Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Velano Vascular Q2 Extension Set

K-Number: K182897 · 2019-03-26

Decision Date2019-03-26
Product CodeFPA
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Velano Vascular Q2 Extension Set is the device name listed in this FDA 510(k) record. The listed applicant is Velano Vascular. It received FDA 510(k) clearance on 2019-03-26 under 510(k) number K182897. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Velano Vascular Q2 Extension Set?

Velano Vascular Q2 Extension Set is a medical device that received FDA 510(k) clearance on 2019-03-26. The listed applicant is Velano Vascular. The 510(k) number is K182897.

When did Velano Vascular Q2 Extension Set receive FDA 510(k) clearance?

Velano Vascular Q2 Extension Set received FDA 510(k) clearance on 2019-03-26, under 510(k) number K182897.

Who is the listed applicant for Velano Vascular Q2 Extension Set?

The FDA 510(k) record lists Velano Vascular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Velano Vascular Q2 Extension Set?

The FDA product code for Velano Vascular Q2 Extension Set is FPA.

Other records listing Velano Vascular as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 7 devices →

Related Devices (Code: FPA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.